PlusVitech, a Seville-based cancer drug development company, has been one of the winners of the World Business Angels Investment Forum (WBAF) 2024, held in Manama, Bahrain

News

This prestigious international event took place on November 19 and 20 at the Four Seasons Hotel Manama, with the presence of over 500 attendees and sponsored by Prince Salman bin Hamad Al Khalifa, the Crown Prince and Prime Minister of the Kingdom of Bahrain. The forum included a global competition known as the Global Fundraising…

Nanoform and PlusVitech partner to repurpose aprepitant as a treatment for lung cancer

News

Helsinki, Finland – April 9, 2024 – Nanoform Finland Plc (“Nanoform”), the medicine performance-enhancing company, today announced a collaboration with PlusVitech, a biotechnology company developing treatments for cancer, to use Nanoform’s state-of-the-art nanomedicine technology to repurpose the anti-nausea medicine aprepitant as a treatment for lung cancer. The development program will include nanoforming the current active ingredient into…